EGFR and diabetic kidney disease: The top 10 core targets of YQWYF for DKD treatment were obtained by network pharmacology including TNF, IL6, AKT1, GAPDH, BCL2, ESR1, SRC, CTNNB1, EGFR, and PPARG.